Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192521 | SCV000247783 | likely benign | not specified | 2015-05-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000231132 | SCV000284828 | benign | Spastic paraplegia | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000192521 | SCV000339799 | benign | not specified | 2016-03-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317697 | SCV000850711 | benign | Inborn genetic diseases | 2017-05-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001529378 | SCV001941145 | benign | not provided | 2018-09-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847869 | SCV002105402 | likely benign | Hereditary spastic paraplegia | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529378 | SCV001742714 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000192521 | SCV001963860 | benign | not specified | no assertion criteria provided | clinical testing |